These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2528510

  • 21. The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass.
    Adluri RK, Singh AV, Skoyles J, Robins A, Hitch A, Baker M, Mitchell IM.
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):988-94. PubMed ID: 19406658
    [Abstract] [Full Text] [Related]

  • 22. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK, Fitch JC, Nussmeier NA, Chen JC, Rollins SA, Mojcik CF, Malloy KJ, Todaro TG, Filloon T, Boyce SW, Gangahar DM, Goldberg M, Saidman LJ, Mangano DT, Pexelizumab Study Investigators.
    Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgery.
    Pea F, Furlanut M, Stellini R, Bonardelli S, Signorini L, Pavan F, Matheis A, Portolani N, Lorenzotti S, Giulini SM, Viale P, Carosi G.
    Int J Antimicrob Agents; 2006 Jan; 27(1):15-9. PubMed ID: 16343858
    [Abstract] [Full Text] [Related]

  • 24. Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine.
    Witczak BJ, Hartmann A, Geiran OR, Bugge JF.
    Eur J Anaesthesiol; 2008 Apr; 25(4):319-25. PubMed ID: 18182121
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacologic C5-complement suppression reduces blood loss during on-pump cardiac surgery.
    Chen JC, Rollins SA, Shernan SK, Boyce S, Allen K, Wallace A, Malloy KJ, Eng JS, Colman RW, Fitch JC, Pexelizumab Study Investigators.
    J Card Surg; 2005 Apr; 20(1):35-41. PubMed ID: 15673408
    [Abstract] [Full Text] [Related]

  • 30. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Shulman R, Singer M, Wilson AP.
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [Abstract] [Full Text] [Related]

  • 31. A comparison of teicoplanin vs. cephradine and metronidazole in surgical prophylaxis: an interim analysis.
    Antrum R, Gorst K, Galvin K, Thornton C, Wynne K, Malata C, Ramsden C, Kester R, Harding I.
    Scand J Infect Dis Suppl; 1990 Feb; 72():45-53. PubMed ID: 1982576
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.
    Nascimento JW, Carmona MJ, Strabelli TM, Auler JO, Santos SR.
    J Hosp Infect; 2005 Apr; 59(4):299-303. PubMed ID: 15749317
    [Abstract] [Full Text] [Related]

  • 34. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
    Lamont E, Seaton RA, Macpherson M, Semple L, Bell E, Thomson AH.
    J Antimicrob Chemother; 2009 Jul; 64(1):181-7. PubMed ID: 19411678
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M, Traina GL, Gentile MG, Fellin G, Rosina R, Cavenaghi L, Buniva G.
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Teicoplanin: Part 2. Evaluation of its use in the biliary system.
    Antrum RM, Bibby SR, Ramsden CH, Kester RC.
    Drugs Exp Clin Res; 1989 Jun; 15(1):25-7. PubMed ID: 2526009
    [Abstract] [Full Text] [Related]

  • 39. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin.
    Wilson AP, Taylor B, Treasure T, Grüneberg RN, Patton K, Felmingham D, Sturridge MF.
    J Antimicrob Chemother; 1988 Feb; 21(2):201-12. PubMed ID: 2966139
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.